Table 3 Clinical outcomes
Non-AAD (n = 166) | AAD (n = 73) | p value | |
|---|---|---|---|
Technical success (at exit from procedure room) | 133 (80.1) | 62 (84.9) | 0.377 |
Device success (at 30 days) | 124 (74.7) | 60 (82.2) | 0.205 |
Periprocedural mortality (at 30 days) | |||
All-cause mortality | 4 (2.4) | 1 (1.4) | 0.609 |
Cardiovascular mortality | 3 (1.8) | 0 (0.0) | 0.251 |
Valve-related mortality | 1 (0.6) | 0 (0.0) | 0.509 |
Early mortality (at 1 year) | |||
All-cause mortality | 15 (9.2) | 3 (5.0) | 0.191 |
Cardiovascular mortality | 12 (7.7) | 1 (2.0) | 0.072 |
Valve-related mortality | 3 (1.9) | 0 (0.0) | 0.245 |
late mortality (at 3 years) | |||
All-cause mortality | 18 (13.1) | 4 (9.5) | 0.201 |
Cardiovascular mortality | 13 (10.0) | 1 (1.9) | 0.056 |
Valve-related mortality | 3 (1.9) | 0 (0.0) | 0.245 |
All stroke | 6 (3.6) | 5 (6.8) | 0.318 |
Myocardial infarction | 5 (3.0) | 1 (1.4) | 0.670 |
VARC type ≥ 2 bleeding | 9 (5.4) | 3 (4.1) | 0.915 |
New permanent pacemaker implantation | 12 (7.2) | 6 (8.2) | 0.789 |
Aortic reintervention or surgery (structural valve deterioration) | 1 (0.6) | 2 (2.7) | 0.222 |
Re-hospitalization | 50 (30.1) | 24 (32.9) | 0.671 |
Cardiovascular hospitalization | 37 (22.3) | 15 (20.5) | |
Non-cardiovascular hospitalization | 13 (7.8) | 9 (12.3) | |
Acute kidney injury (stage 2–4) | 1 (1.8) | 1 (4.3) | 0.500 |
Paravalvular leakage | 1 (0.6) | 2 (2.7) | 0.222 |
Cardiac tamponade | 0 (0.0) | 0 (0.0) | – |
Aortic dissection | 0 (0.0) | 0 (0.0) | – |